View New Articles By
We reached out to our Damon Runyon current awardees, alumni, and committee members last week with the following message. We are sharing this message with the public because science is not insulated from the outside world and has always reflected the priorities and prejudices of the society it resides in. Racism and bias are not relics of a less enlightened past, but living, active forces that hold us back from scientific breakthroughs.
The Damon Runyon Cancer Research Foundation has named five brilliant doctors with novel approaches to fighting cancer as Damon Runyon Physician-Scientists. Grants totaling $2.3 million will provide them the opportunity to gain skills and experience in translational and clinical research.
The first class of Damon Runyon Quantitative Biology Fellowship Awardees launched their research in novel directions that may lead to the next breakthroughs in cancer research. Nine brilliant young scientists will apply their quantitative skills to design innovative experiments and interpret massive data sets that may help solve important biological and clinical problems.
COVID-19 related laboratory shutdowns threaten to derail scientists in the critical earliest stages of their careers. In response, the Damon Runyon Cancer Research Foundation is extending funding for those Damon Runyon scientists most affected by the current crisis, totaling an additional investment of up to $1,170,000 during the upcoming fiscal year. Watch our webinar as our scientists discuss the challenges of doing research during the COVID-19 pandemic.
Former Damon Runyon Fellow Aaron D. Viny, MD, cares for people with leukemia and myelodysplastic syndrome (MDS) at Memorial Sloan Kettering as an oncologist specializing in blood cancers. Recently, Dr. Viny spent two weeks treating cancer patients in the midst of the COVID-19 pandemic. Here are his reflections, from his twitter thread, as a physician-scientist at a unique time in medical history.
Co-Authored by Damon Runyon Fellow Caroline Bartman, PhD, and Sponsor Joshua Rabinowitz, MD, PhD, and published in the New York Times
As with any other poison, viruses are usually deadlier in larger amounts.
We’re thrilled to welcome Judy Swanson to the Damon Runyon Board of Directors this year. Judy is passionate about encouraging science and innovation at all levels, which is one of the reasons she supports Damon Runyon. Judy has been a member of the Damon Runyon Bay Area Committee since January 2017.
While parents have been coaxing kids to eat more vegetables for generations, only recently have researchers delved into understanding the science behind the health benefits. Elizabeth S. Sattely, PhD (Damon Runyon Fellow ‘08-‘10), has been at the forefront of this trend to harness plant chemistry to improve human health.
From all of us at the Damon Runyon Cancer Research Foundation, we sincerely hope that you are safe and healthy. We are aware that everyone is affected by COVID-19/novel coronavirus, from our scientists to our donors.
Advances in Genome Biology and Technology (AGBT) and the Damon Runyon Cancer Research Foundation have partnered to award a new fellowship in honor of world-renowned genomics pioneer, Elaine R. Mardis, PhD. Steven W. M. Crossley, PhD, at the University of California, Berkeley, will receive this award during the AGBT General Meeting to be held February.
CONNECT
1.877.7CANCER
info@damonrunyon.org
One Exchange Plaza
55 Broadway, Suite 302
New York, NY 10006
